MUNICH, Germany, Sept. 29 /PRNewswire/ -- NOMAD Bioscience GmbH, Munich, Germany (NOMAD) is a private biotechnology company developing plant-made biomaterials and biopharmaceuticals that address critical unmet needs. NOMAD is developing a series of high-value products such as nanopatterned materials, protein scaffolds and templates, proteins and enzymes for important markets including biofuels, electric batteries, and biopharmaceuticals.
Nomad's plant-based protein expression technologies are being licensed from several companies for a broad range of products. NOMAD's proprietary technologies further improve the upstream part of the manufacturing process, but most importantly, they provide for novel downstream solutions that together with the in-licensed upstream components should result in a superior fully integrated manufacturing process for most of NOMAD's intended products. Another major focus of NOMAD is innovations that provide for full integration of the novel process components and novel product parts into existing industrial processes/products.
NOMAD's biomaterial pipeline consists of several selected product candidates, including plant-made cellulase enzymes (expected impact: up to 30% lower manufacturing cost of bioethanol), nanostructured polyadsorbents for affinity purification of biopharmaceuticals (low cost polyaffinity nanoparticles that replace expensive current affinity resins) and nanopatterned electrodes (batteries with improved electrochemical cycling properties and electrode capacity).
NOMAD's pharmaceutical portfolio is focused on three 'biosimilar'
versions of the proteins currently constituting a $15 B market: Insulin,
Etanercept (Enbrel(R)), and Trastuzumab (Herceptin(R)). Our lead
pharmaceutical product, Insulin, targets the US$7.5 billion Insulin market.
NOMAD's Insulin will provide an economical alternative to commercially
available Insulin to better serve developing nations and meet the
anticipated surge in d
|SOURCE NOMAD Bioscience GmbH|
Copyright©2008 PR Newswire.
All rights reserved